KORU MEDICAL SYSTEMS, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2025-10-15: Study NCT07189013; Company role Lead sponsor; Phase Not applicable; Status Not yet recruiting.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2025-10-15 | NCT07189013 Assessing Patient Preference for Infusion Systems | Lead sponsor | Not applicable | Not yet recruiting | Primary Immunodeficiencies (PID); Secondary Immunodeficiencies (SID) | 52 | 2026-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |